SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance

A Bak; M A Mugglestone; N V Ratnaraja; J A Wilson; L Rivett; S M Stoneham; J Bostock; S E Moses; J R Price; M Weinbren; H P Loveday; J Islam; A P R Wilson

doi:10.1016/j.jhin.2021.04.027

SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance

J Hosp Infect. 2021 Aug:114:79-103. doi: 10.1016/j.jhin.2021.04.027. Epub 2021 May 1.

Authors

A Bak¹, M A Mugglestone², N V Ratnaraja³, J A Wilson⁴, L Rivett⁵, S M Stoneham⁶, J Bostock⁷, S E Moses⁸, J R Price⁹, M Weinbren¹⁰, H P Loveday⁴, J Islam⁶, A P R Wilson¹¹

Affiliations

¹ Healthcare Infection Society, UK. Electronic address: aggie.bak@his.org.uk.
² Healthcare Infection Society, UK.
³ British Infection Association, UK; University Hospitals Coventry & Warwickshire NHS Trust, UK.
⁴ Infection Prevention Society, UK; Richard Wells Research Centre, University of West London, UK.
⁵ Healthcare Infection Society, UK; Cambridge University NHS Hospitals Foundation Trust, UK.
⁶ Healthcare Infection Society, UK; Brighton and Sussex University Hospitals NHS Trust, UK.
⁷ Lay Member, UK.
⁸ British Infection Association, UK; Royal College of Pathologists, UK; East Kent Hospitals University NHS Foundation Trust, UK.
⁹ Healthcare Infection Society, UK; Imperial College Healthcare NHS Trust, UK.
¹⁰ Healthcare Infection Society, UK; Sherwood Forest Hospitals NHS Foundation Trust, UK.
¹¹ Healthcare Infection Society, UK; University College London Hospitals NHS Foundation Trust, UK.

No abstract available

Keywords: COVID-19; SARS-CoV-2; aerosol transmission; droplet transmission; guidelines; infection prevention; infectious disease transmission; infectious diseases.

MeSH terms

Aerosols
COVID-19*
Delivery of Health Care
Humans
Infectious Disease Transmission, Patient-to-Professional
Pathologists
SARS-CoV-2*

Substances

Aerosols